Review



mouse monoclonal anti cdc2 p34  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Santa Cruz Biotechnology mouse monoclonal anti cdc2 p34
    Mouse Monoclonal Anti Cdc2 P34, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1558 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cdc2+p34/Cdc2/pmc12887411-266-62-70
    Average 96 stars, based on 1558 article reviews
    mouse monoclonal anti cdc2 p34 - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    Immunofluorescence:

    Article Title: The Aurora B inhibitor ZM-447439 induces caspase-independent necrosis-like death in v-Src oncogene-expressing cells via accumulation of extra-lysosomal cathepsin B.
    Article Snippet: Src signaling is aberrantly activated in various cancers, and therapeutic strategies targeting Src-dependent cancers have been developed.. We previously reported that cells expressing the oncogenic mutant v-Src are resistant to microtubule-targeting agents (MTAs), yet paradoxically exhibiting sensitivity to the Aurora B inhibitor ZM-447439; however, the mechanism underlying this cytotoxicity remains unclear.. In this study, we demonstrate that the Aurora B inhibitor ZM-447439 potentiates cell death in v-Src-expressing HeLa S3 and HCT116 cells, accompanied by the accumulation of tetraploid and polyploid cells.

    Article Title: Identification of a novel Bax-Cdk1 signalling complex that links activation of the mitotic checkpoint to apoptosis.
    Article Snippet: Cells were synchronised in S-phase with thymidine (2 mM) for 24 h, washed with PBS and released into fresh medium containing 60 nM Taxol (Sigma, Poole, UK) for 0–36 h. For inhibition of Cdk1 kinase, synchronised cells that were arrested in mitosis by Taxol (60 nM for 12 h) were treated with RO3306 (Tocris Bioscience, Bristol, UK) at a concentration of 1 or 5 μM for 4 h. .. Antibodies against the following proteins were used for immunoblotting (IB), immunoprecipitation (IP) or immunofluorescence (IF): Bak (N-20, Sc1035, 1:500 for IP), Cdc2 p34 (C-19, Sc-954; 1:1000), Cdc2 p34 (17, Sc-54, 1:500 for IP), Bax (6A7, used for Bax IP only, 1:500 dilution) and αPAK (N-20, Sc-1035; 1:1000) were purchased from Santa Cruz Biotechnology (TX, USA); Bak (D4E4, 12105; 1:1000), phospho-Bcl-2 (Ser70, 2827; 1:1000), Bcl-xL (2762; 1:1000), cyclin B1 (4138; 1:1000), phospho-Cdc2 (Tyr15, 9111; 1:1000), ANT2/SLC25A5 (14671; 1:1000), VDAC (4866; 1:1000), and goat anti-rabbit-IgG, HRP-linked antibody and Bax (#2772, used for IB only; 1:1000) were purchased from Cell Signaling Technology; goat anti-mouse-IgG, HRP-linked antibody (1:5000 for IB) and rabbit IgG (1:500 for IP) were purchased from Bethyl; and also Bcl-xL (BD Transduction Laboratories, 610212; 1:1000), M30 CytoDEATH (Roche, Jo u rn al o f Ce ll Sc ie n ce 2140322, 1:10 for IF), poly-(ADP-Ribose) polymerase (PARP) (Roche, 11835238001; 1:2000), BcL-2 Clone 124 (Dako, M0887; 1:1000), phospho-Bcl-xL (Ser62, GTX79124; 1:1000) (Gene Tex), α-tubulin (Sigma, 37981, 1:5000 for IB) and Alexa Fluor 488 goat anti-mouse-IgG (Life Technologies, 1:1000 for IF). .. N-terminus-GST-Cdk1 was purchased from Sino Biological Inc (Beijing, China); N-terminus-GST-Bax was purchased fromNovus Biologicals (CO, USA), GST–PAKαwas purified as described previously (Deacon et al., 2003).

    Western Blot:

    Article Title: The Aurora B inhibitor ZM-447439 induces caspase-independent necrosis-like death in v-Src oncogene-expressing cells via accumulation of extra-lysosomal cathepsin B.
    Article Snippet: Src signaling is aberrantly activated in various cancers, and therapeutic strategies targeting Src-dependent cancers have been developed.. We previously reported that cells expressing the oncogenic mutant v-Src are resistant to microtubule-targeting agents (MTAs), yet paradoxically exhibiting sensitivity to the Aurora B inhibitor ZM-447439; however, the mechanism underlying this cytotoxicity remains unclear.. In this study, we demonstrate that the Aurora B inhibitor ZM-447439 potentiates cell death in v-Src-expressing HeLa S3 and HCT116 cells, accompanied by the accumulation of tetraploid and polyploid cells.

    Article Title: Proliferative Effect of Aqueous Extract of Sea Cucumber ( Holothuria parva ) Body Wall on Human Umbilical Cord Mesenchymal Stromal/Stem Cells
    Article Snippet: .. Immunoblotting was performed with β-actin (c4): sc-47778 (Santa Cruz Biotechnology, San Diego, CA, USA), cdc2 p34 (17): sc-54 (Santa Cruz Biotechnology), CDK-4 (DCS-35): sc-23896 (Santa Cruz Biotechnology), cdk6 (b-10): sc-7961 (Santa Cruz Biotechnology), cyclin D1 (a-12): sc-8396 (Santa Cruz Biotechnology), cyclin D3 (1): sc-135875 (Santa Cruz Biotechnology), cyclin E (he12): sc-247 (Santa Cruz Biotechnology), ERK 1/2 (h-72): sc-292838 (Santa Cruz Biotechnology), HIF-1α (28b): sc-13515 (Santa Cruz Biotechnology), p21 (f-5): sc-6246 (Santa Cruz Biotechnology), PCNA (pc11): sc-53407 (Santa Cruz Biotechnology), and TERT polyclonal antibody e-ab-33070 (Elabscience Biotechnology, Wuhan, China). .. Membranes were washed 3 times (10 min each time) in tris-buffered saline before incubating with m-IgGκBP-HRP: sc-516102 (Santa Cruz Biotechnology) or mouse anti-rabbit IgG-HRP: sc-2357 (Santa Cruz Biotechnology) secondary antibodies.

    Article Title: Identification of a novel Bax-Cdk1 signalling complex that links activation of the mitotic checkpoint to apoptosis.
    Article Snippet: Cells were synchronised in S-phase with thymidine (2 mM) for 24 h, washed with PBS and released into fresh medium containing 60 nM Taxol (Sigma, Poole, UK) for 0–36 h. For inhibition of Cdk1 kinase, synchronised cells that were arrested in mitosis by Taxol (60 nM for 12 h) were treated with RO3306 (Tocris Bioscience, Bristol, UK) at a concentration of 1 or 5 μM for 4 h. .. Antibodies against the following proteins were used for immunoblotting (IB), immunoprecipitation (IP) or immunofluorescence (IF): Bak (N-20, Sc1035, 1:500 for IP), Cdc2 p34 (C-19, Sc-954; 1:1000), Cdc2 p34 (17, Sc-54, 1:500 for IP), Bax (6A7, used for Bax IP only, 1:500 dilution) and αPAK (N-20, Sc-1035; 1:1000) were purchased from Santa Cruz Biotechnology (TX, USA); Bak (D4E4, 12105; 1:1000), phospho-Bcl-2 (Ser70, 2827; 1:1000), Bcl-xL (2762; 1:1000), cyclin B1 (4138; 1:1000), phospho-Cdc2 (Tyr15, 9111; 1:1000), ANT2/SLC25A5 (14671; 1:1000), VDAC (4866; 1:1000), and goat anti-rabbit-IgG, HRP-linked antibody and Bax (#2772, used for IB only; 1:1000) were purchased from Cell Signaling Technology; goat anti-mouse-IgG, HRP-linked antibody (1:5000 for IB) and rabbit IgG (1:500 for IP) were purchased from Bethyl; and also Bcl-xL (BD Transduction Laboratories, 610212; 1:1000), M30 CytoDEATH (Roche, Jo u rn al o f Ce ll Sc ie n ce 2140322, 1:10 for IF), poly-(ADP-Ribose) polymerase (PARP) (Roche, 11835238001; 1:2000), BcL-2 Clone 124 (Dako, M0887; 1:1000), phospho-Bcl-xL (Ser62, GTX79124; 1:1000) (Gene Tex), α-tubulin (Sigma, 37981, 1:5000 for IB) and Alexa Fluor 488 goat anti-mouse-IgG (Life Technologies, 1:1000 for IF). .. N-terminus-GST-Cdk1 was purchased from Sino Biological Inc (Beijing, China); N-terminus-GST-Bax was purchased fromNovus Biologicals (CO, USA), GST–PAKαwas purified as described previously (Deacon et al., 2003).

    Article Title: Proliferative effect of aqueous extract of sea cucumber (Holothuria parva) body wall on human umbilical cord mesenchymal stromal/stem cells
    Article Snippet: .. Immunoblotting was performed with β-actin (c4): sc-47778 (Santa Cruz Biotechnology), cdc2 p34 (17): sc54 (Santa Cruz Biotechnology), cdk-4 (dcs-35): sc-23896 (Santa Cruz Biotechnology), cdk6 (b-10): sc-7961 (Santa Cruz Biotechnology), cyclin D1 (a-12): sc-8396 (Santa Cruz Biotechnology), cyclin D3 (1): sc-135875 (Santa Cruz Biotechnology), cyclin E (he12): sc-247 (Santa Cruz Biotechnology), ERK 1/2 (h-72): sc-292838 (Santa Cruz Biotechnology), HIF-1α (28b): sc-13515 (Santa Cruz Biotechnology), p21 (f-5): sc-6246 (Santa Cruz Biotechnology), PCNA (pc11): sc-53407 (Santa Cruz Biotechnology), and TERT polyclonal antibody eab-33070 (Elabscience Biotechnology). .. Membranes were washed 3 times (10 min each) in Tris-buffered saline before incubating with m-IgGκBP-HRP: sc-516102 (Santa Cruz Biotechnology) or mouse anti-rabbit IgG-HRP: sc-2357 (Santa Cruz Biotechnology) secondary antibodies.

    Flow Cytometry:

    Article Title: The Aurora B inhibitor ZM-447439 induces caspase-independent necrosis-like death in v-Src oncogene-expressing cells via accumulation of extra-lysosomal cathepsin B.
    Article Snippet: Src signaling is aberrantly activated in various cancers, and therapeutic strategies targeting Src-dependent cancers have been developed.. We previously reported that cells expressing the oncogenic mutant v-Src are resistant to microtubule-targeting agents (MTAs), yet paradoxically exhibiting sensitivity to the Aurora B inhibitor ZM-447439; however, the mechanism underlying this cytotoxicity remains unclear.. In this study, we demonstrate that the Aurora B inhibitor ZM-447439 potentiates cell death in v-Src-expressing HeLa S3 and HCT116 cells, accompanied by the accumulation of tetraploid and polyploid cells.

    other:

    Article Title: Bisphenol A exposure inhibits vascular smooth muscle cell responses: Involvement of proliferation, migration, and invasion.
    Article Snippet: Previous studies have associated bisphenol A (BPA) with malignant tumor formation, infertility, and atherosclerosis in vitro and in vivo.. However, the precise mechanisms through which BPA affects the cardiovascular system under normal conditions remain unclear.. Therefore, this study investigated the biological mechanisms through which BPA affects the responses of aortic vascular smooth muscle cells (VSMCs).

    Membrane:

    Article Title: PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer
    Article Snippet: .. Briefly, 40-50 μg of lysate was resolved by SDS-PAGE, transferred to nitrile membrane and analyzed using the following antibodies: P21 (1:1000, Abcam ab109520), phospho-CDC2 (Tyr15) (1:1500, Cell Signaling Technology 9111S), CDC2 p34 (1:200, Santa Cruz Biotechnology Sc-54) and Vinculin (1:1000, Sigma-Aldrich V9264-200uL) .. C4-2 cells were cultured and lifted from plates by trypsinization then re-suspended in 100 mL of 50% Matrigel (BD Biosciences) and saline mixture followed by subcutaneous injection in two separate groups of castrated and non-castrated athymic nude mice (age at least 6 weeks old).

    Article Title: PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer
    Article Snippet: .. Briefly, 40–50 μg of lysate was resolved by SDS-PAGE, transferred to nitrile membrane and analyzed using the following antibodies: P21 (1:1000, Abcam ab109520), phospho-CDC2 (Tyr15) (1:1500, Cell Signaling Technology 9111S), CDC2 p34 (1:200, Santa Cruz Biotechnology Sc-54) and Vinculin (1:1000, Sigma-Aldrich V9264-200uL) .. C4-2 cells were cultured and lifted from plates by trypsinization then re-suspended in 100 mL of 50% Matrigel (BD Biosciences) and saline mixture followed by subcutaneous injection in two separate groups of castrated and non-castrated athymic nude mice (age at least 6 weeks old).

    Immunoprecipitation:

    Article Title: Identification of a novel Bax-Cdk1 signalling complex that links activation of the mitotic checkpoint to apoptosis.
    Article Snippet: Cells were synchronised in S-phase with thymidine (2 mM) for 24 h, washed with PBS and released into fresh medium containing 60 nM Taxol (Sigma, Poole, UK) for 0–36 h. For inhibition of Cdk1 kinase, synchronised cells that were arrested in mitosis by Taxol (60 nM for 12 h) were treated with RO3306 (Tocris Bioscience, Bristol, UK) at a concentration of 1 or 5 μM for 4 h. .. Antibodies against the following proteins were used for immunoblotting (IB), immunoprecipitation (IP) or immunofluorescence (IF): Bak (N-20, Sc1035, 1:500 for IP), Cdc2 p34 (C-19, Sc-954; 1:1000), Cdc2 p34 (17, Sc-54, 1:500 for IP), Bax (6A7, used for Bax IP only, 1:500 dilution) and αPAK (N-20, Sc-1035; 1:1000) were purchased from Santa Cruz Biotechnology (TX, USA); Bak (D4E4, 12105; 1:1000), phospho-Bcl-2 (Ser70, 2827; 1:1000), Bcl-xL (2762; 1:1000), cyclin B1 (4138; 1:1000), phospho-Cdc2 (Tyr15, 9111; 1:1000), ANT2/SLC25A5 (14671; 1:1000), VDAC (4866; 1:1000), and goat anti-rabbit-IgG, HRP-linked antibody and Bax (#2772, used for IB only; 1:1000) were purchased from Cell Signaling Technology; goat anti-mouse-IgG, HRP-linked antibody (1:5000 for IB) and rabbit IgG (1:500 for IP) were purchased from Bethyl; and also Bcl-xL (BD Transduction Laboratories, 610212; 1:1000), M30 CytoDEATH (Roche, Jo u rn al o f Ce ll Sc ie n ce 2140322, 1:10 for IF), poly-(ADP-Ribose) polymerase (PARP) (Roche, 11835238001; 1:2000), BcL-2 Clone 124 (Dako, M0887; 1:1000), phospho-Bcl-xL (Ser62, GTX79124; 1:1000) (Gene Tex), α-tubulin (Sigma, 37981, 1:5000 for IB) and Alexa Fluor 488 goat anti-mouse-IgG (Life Technologies, 1:1000 for IF). .. N-terminus-GST-Cdk1 was purchased from Sino Biological Inc (Beijing, China); N-terminus-GST-Bax was purchased fromNovus Biologicals (CO, USA), GST–PAKαwas purified as described previously (Deacon et al., 2003).



    Similar Products

    96
    Santa Cruz Biotechnology mouse monoclonal anti cdc2 p34
    Mouse Monoclonal Anti Cdc2 P34, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cdc2+p34/Cdc2/pmc12887411-266-62-70
    Average 96 stars, based on 1 article reviews
    mouse monoclonal anti cdc2 p34 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology p cdk1
    CDRs ablation suppressed prostate cancer cell proliferation. (A) The circuit diagram illustrates the correlation among CDRs co-expressed gene sets. (B) Venn analysis of the overlap of CDRs co-expressed genes. (C) The heatmap shows the relative expression of CDRs overlapped co-expressed genes in patients with NE signature high and low groups. (D – F) The heatmap illustrates the correlation of CDRs co-expressed genes with CDRs in ADPC (D) and CRPC (E, F) patient cohorts. (G, H) KEGG pathway analysis (G) and GSEA analysis (H) of enriched biological processes of CDRs and CDRs co-expressed genes. (I, J) The diagram illustrates the working model of CRISPR-Cas13 for RNA silencing and knockdown efficiency of CDRs with the corresponding gRNAs. (K, L) Cell growth assays indicate the impact of CDRs knockdown on the viability of different prostate cancer cells. (M) Western blotting analysis of the expression of cell cycle-regulated genes, including CCND1, <t>CDK1,</t> and p-CDK1, after CDRs knockdown. ∗∗ p < 0.01. CDRs refers to CDC20 (cell division cycle 20), DTL (denticleless E3 ubiquitin protein ligase), and RRM2 (ribonucleotide reductase M2). NE, neuroendocrine; KEGG, Kyoto Encyclopedia of Genes and Genomes; GSEA, gene set enrichment analysis; CCND1, cyclin D1; CDK1, cyclin-dependent kinase 1.
    P Cdk1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cdc2+p34/p-Cdc2+p34+Antibody/pmc12765100-48-10-11
    Average 93 stars, based on 1 article reviews
    p cdk1 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology anti cdk1
    CDRs ablation suppressed prostate cancer cell proliferation. (A) The circuit diagram illustrates the correlation among CDRs co-expressed gene sets. (B) Venn analysis of the overlap of CDRs co-expressed genes. (C) The heatmap shows the relative expression of CDRs overlapped co-expressed genes in patients with NE signature high and low groups. (D – F) The heatmap illustrates the correlation of CDRs co-expressed genes with CDRs in ADPC (D) and CRPC (E, F) patient cohorts. (G, H) KEGG pathway analysis (G) and GSEA analysis (H) of enriched biological processes of CDRs and CDRs co-expressed genes. (I, J) The diagram illustrates the working model of CRISPR-Cas13 for RNA silencing and knockdown efficiency of CDRs with the corresponding gRNAs. (K, L) Cell growth assays indicate the impact of CDRs knockdown on the viability of different prostate cancer cells. (M) Western blotting analysis of the expression of cell cycle-regulated genes, including CCND1, <t>CDK1,</t> and p-CDK1, after CDRs knockdown. ∗∗ p < 0.01. CDRs refers to CDC20 (cell division cycle 20), DTL (denticleless E3 ubiquitin protein ligase), and RRM2 (ribonucleotide reductase M2). NE, neuroendocrine; KEGG, Kyoto Encyclopedia of Genes and Genomes; GSEA, gene set enrichment analysis; CCND1, cyclin D1; CDK1, cyclin-dependent kinase 1.
    Anti Cdk1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cdc2+p34/Cdc2+p34+Antibody/pmc12774666-60-24-25
    Average 96 stars, based on 1 article reviews
    anti cdk1 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology mouse monoclonal anticdc2 p34
    CDRs ablation suppressed prostate cancer cell proliferation. (A) The circuit diagram illustrates the correlation among CDRs co-expressed gene sets. (B) Venn analysis of the overlap of CDRs co-expressed genes. (C) The heatmap shows the relative expression of CDRs overlapped co-expressed genes in patients with NE signature high and low groups. (D – F) The heatmap illustrates the correlation of CDRs co-expressed genes with CDRs in ADPC (D) and CRPC (E, F) patient cohorts. (G, H) KEGG pathway analysis (G) and GSEA analysis (H) of enriched biological processes of CDRs and CDRs co-expressed genes. (I, J) The diagram illustrates the working model of CRISPR-Cas13 for RNA silencing and knockdown efficiency of CDRs with the corresponding gRNAs. (K, L) Cell growth assays indicate the impact of CDRs knockdown on the viability of different prostate cancer cells. (M) Western blotting analysis of the expression of cell cycle-regulated genes, including CCND1, <t>CDK1,</t> and p-CDK1, after CDRs knockdown. ∗∗ p < 0.01. CDRs refers to CDC20 (cell division cycle 20), DTL (denticleless E3 ubiquitin protein ligase), and RRM2 (ribonucleotide reductase M2). NE, neuroendocrine; KEGG, Kyoto Encyclopedia of Genes and Genomes; GSEA, gene set enrichment analysis; CCND1, cyclin D1; CDK1, cyclin-dependent kinase 1.
    Mouse Monoclonal Anticdc2 P34, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cdc2+p34/Cdc2+p34+Antibody/pm41534835-186-69-76
    Average 96 stars, based on 1 article reviews
    mouse monoclonal anticdc2 p34 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology cdk1
    CDRs ablation suppressed prostate cancer cell proliferation. (A) The circuit diagram illustrates the correlation among CDRs co-expressed gene sets. (B) Venn analysis of the overlap of CDRs co-expressed genes. (C) The heatmap shows the relative expression of CDRs overlapped co-expressed genes in patients with NE signature high and low groups. (D – F) The heatmap illustrates the correlation of CDRs co-expressed genes with CDRs in ADPC (D) and CRPC (E, F) patient cohorts. (G, H) KEGG pathway analysis (G) and GSEA analysis (H) of enriched biological processes of CDRs and CDRs co-expressed genes. (I, J) The diagram illustrates the working model of CRISPR-Cas13 for RNA silencing and knockdown efficiency of CDRs with the corresponding gRNAs. (K, L) Cell growth assays indicate the impact of CDRs knockdown on the viability of different prostate cancer cells. (M) Western blotting analysis of the expression of cell cycle-regulated genes, including CCND1, <t>CDK1,</t> and p-CDK1, after CDRs knockdown. ∗∗ p < 0.01. CDRs refers to CDC20 (cell division cycle 20), DTL (denticleless E3 ubiquitin protein ligase), and RRM2 (ribonucleotide reductase M2). NE, neuroendocrine; KEGG, Kyoto Encyclopedia of Genes and Genomes; GSEA, gene set enrichment analysis; CCND1, cyclin D1; CDK1, cyclin-dependent kinase 1.
    Cdk1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cdc2+p34/Cdc2+p34+Antibody/pm41365883-345-76-78
    Average 96 stars, based on 1 article reviews
    cdk1 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology py15 cdk1
    CDRs ablation suppressed prostate cancer cell proliferation. (A) The circuit diagram illustrates the correlation among CDRs co-expressed gene sets. (B) Venn analysis of the overlap of CDRs co-expressed genes. (C) The heatmap shows the relative expression of CDRs overlapped co-expressed genes in patients with NE signature high and low groups. (D – F) The heatmap illustrates the correlation of CDRs co-expressed genes with CDRs in ADPC (D) and CRPC (E, F) patient cohorts. (G, H) KEGG pathway analysis (G) and GSEA analysis (H) of enriched biological processes of CDRs and CDRs co-expressed genes. (I, J) The diagram illustrates the working model of CRISPR-Cas13 for RNA silencing and knockdown efficiency of CDRs with the corresponding gRNAs. (K, L) Cell growth assays indicate the impact of CDRs knockdown on the viability of different prostate cancer cells. (M) Western blotting analysis of the expression of cell cycle-regulated genes, including CCND1, <t>CDK1,</t> and p-CDK1, after CDRs knockdown. ∗∗ p < 0.01. CDRs refers to CDC20 (cell division cycle 20), DTL (denticleless E3 ubiquitin protein ligase), and RRM2 (ribonucleotide reductase M2). NE, neuroendocrine; KEGG, Kyoto Encyclopedia of Genes and Genomes; GSEA, gene set enrichment analysis; CCND1, cyclin D1; CDK1, cyclin-dependent kinase 1.
    Py15 Cdk1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cdc2+p34/p-Cdc2+p34+Antibody/pm41365883-346-52-54
    Average 93 stars, based on 1 article reviews
    py15 cdk1 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology primary antibodies against cdc2
    CDRs ablation suppressed prostate cancer cell proliferation. (A) The circuit diagram illustrates the correlation among CDRs co-expressed gene sets. (B) Venn analysis of the overlap of CDRs co-expressed genes. (C) The heatmap shows the relative expression of CDRs overlapped co-expressed genes in patients with NE signature high and low groups. (D – F) The heatmap illustrates the correlation of CDRs co-expressed genes with CDRs in ADPC (D) and CRPC (E, F) patient cohorts. (G, H) KEGG pathway analysis (G) and GSEA analysis (H) of enriched biological processes of CDRs and CDRs co-expressed genes. (I, J) The diagram illustrates the working model of CRISPR-Cas13 for RNA silencing and knockdown efficiency of CDRs with the corresponding gRNAs. (K, L) Cell growth assays indicate the impact of CDRs knockdown on the viability of different prostate cancer cells. (M) Western blotting analysis of the expression of cell cycle-regulated genes, including CCND1, <t>CDK1,</t> and p-CDK1, after CDRs knockdown. ∗∗ p < 0.01. CDRs refers to CDC20 (cell division cycle 20), DTL (denticleless E3 ubiquitin protein ligase), and RRM2 (ribonucleotide reductase M2). NE, neuroendocrine; KEGG, Kyoto Encyclopedia of Genes and Genomes; GSEA, gene set enrichment analysis; CCND1, cyclin D1; CDK1, cyclin-dependent kinase 1.
    Primary Antibodies Against Cdc2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cdc2+p34/Cdc2+p34+Antibody/pm41349910-65-0-29
    Average 96 stars, based on 1 article reviews
    primary antibodies against cdc2 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    Image Search Results


    CDRs ablation suppressed prostate cancer cell proliferation. (A) The circuit diagram illustrates the correlation among CDRs co-expressed gene sets. (B) Venn analysis of the overlap of CDRs co-expressed genes. (C) The heatmap shows the relative expression of CDRs overlapped co-expressed genes in patients with NE signature high and low groups. (D – F) The heatmap illustrates the correlation of CDRs co-expressed genes with CDRs in ADPC (D) and CRPC (E, F) patient cohorts. (G, H) KEGG pathway analysis (G) and GSEA analysis (H) of enriched biological processes of CDRs and CDRs co-expressed genes. (I, J) The diagram illustrates the working model of CRISPR-Cas13 for RNA silencing and knockdown efficiency of CDRs with the corresponding gRNAs. (K, L) Cell growth assays indicate the impact of CDRs knockdown on the viability of different prostate cancer cells. (M) Western blotting analysis of the expression of cell cycle-regulated genes, including CCND1, CDK1, and p-CDK1, after CDRs knockdown. ∗∗ p < 0.01. CDRs refers to CDC20 (cell division cycle 20), DTL (denticleless E3 ubiquitin protein ligase), and RRM2 (ribonucleotide reductase M2). NE, neuroendocrine; KEGG, Kyoto Encyclopedia of Genes and Genomes; GSEA, gene set enrichment analysis; CCND1, cyclin D1; CDK1, cyclin-dependent kinase 1.

    Journal: Genes & Diseases

    Article Title: Integrative high-throughput studies to develop novel targets and drugs for the treatment of advanced prostate cancer

    doi: 10.1016/j.gendis.2025.101732

    Figure Lengend Snippet: CDRs ablation suppressed prostate cancer cell proliferation. (A) The circuit diagram illustrates the correlation among CDRs co-expressed gene sets. (B) Venn analysis of the overlap of CDRs co-expressed genes. (C) The heatmap shows the relative expression of CDRs overlapped co-expressed genes in patients with NE signature high and low groups. (D – F) The heatmap illustrates the correlation of CDRs co-expressed genes with CDRs in ADPC (D) and CRPC (E, F) patient cohorts. (G, H) KEGG pathway analysis (G) and GSEA analysis (H) of enriched biological processes of CDRs and CDRs co-expressed genes. (I, J) The diagram illustrates the working model of CRISPR-Cas13 for RNA silencing and knockdown efficiency of CDRs with the corresponding gRNAs. (K, L) Cell growth assays indicate the impact of CDRs knockdown on the viability of different prostate cancer cells. (M) Western blotting analysis of the expression of cell cycle-regulated genes, including CCND1, CDK1, and p-CDK1, after CDRs knockdown. ∗∗ p < 0.01. CDRs refers to CDC20 (cell division cycle 20), DTL (denticleless E3 ubiquitin protein ligase), and RRM2 (ribonucleotide reductase M2). NE, neuroendocrine; KEGG, Kyoto Encyclopedia of Genes and Genomes; GSEA, gene set enrichment analysis; CCND1, cyclin D1; CDK1, cyclin-dependent kinase 1.

    Article Snippet: The primary antibodies used in this study were as follows: p-CDK1 (Santa Cruz Biotechnology sc-136,014, 1:500), CDK1 (ABclonal A12414, 1:1000), CCND1 (ABclonal A19038, 1:1000), and ACTB (Servicebio GB15001, 1:2000).

    Techniques: Expressing, CRISPR, Knockdown, Western Blot, Ubiquitin Proteomics